← Leaderboards
M Saeed Sheikh
Upstate Medical University
$3,525,227
Attributed
$3,525,227
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $474.8K · FY2005–12$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$3,525,227 · 8
By mechanism
R21$1,956,353 · 5
R01$1,257,561 · 1
R03$311,313 · 2
Top collaborators
No co-investigators on record.
Most similar at Upstate Medical University
Same institution · by research overlap
- Ying Huang$2,446,524
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisMolecularProteinsInsightBaseMalignant NeoplasmsGenesCellsMediatingDna DamageResponseGene ExpressionTransfection /Expression VectorApoptoticSignal TransductionStressOutcome StudyNormal Tissue MorphologyMessenger RnaAffectComplexBiological Signal TransductionNamesTumor
Grant awards (19)
A novel biomarker and therapeutic target for breast cancer$173,456
R21 · FY2012 · CA · contact PI
Development of dihydroartemisinin as a novel preventive agent for prostate cancer$79,750
R03 · FY2012 · CA · contact PI
A novel biomarker and therapeutic target for breast cancer$207,332
R21 · FY2011 · CA · contact PI
Development of dihydroartemisinin as a novel preventive agent for prostate cancer$79,563
R03 · FY2011 · CA · contact PI
Characterization of a novel stress-regulated anti-apoptotic ubiquitin ligase$196,250
R21 · FY2009 · ES · contact PI
Characterization of a novel stress-regulated anti-apoptotic ubiquitin ligase$235,500
R21 · FY2008 · ES · contact PI
PDRG, a novel p53 and DNA damage-regulated gene and colorectal cancer$192,325
R21 · FY2008 · ES · contact PI
PDRG, a novel p53 and DNA damage-regulated gene and colorectal cancer$235,000
R21 · FY2007 · ES · contact PI
Characterization:novel genotoxic stress-regulated gene$184,490
R21 · FY2007 · ES · contact PI
Characterization of a Novel Growth Regulator$246,761
R01 · FY2006 · CA · contact PI
Characterization:novel genotoxic stress-regulated gene$228,000
R21 · FY2006 · ES · contact PI
Characterization of a Novel Growth Regulator$252,700
R01 · FY2005 · CA
Characterization of a Novel Growth Regulator$252,700
R01 · FY2004 · CA
COX-2 and p53 interactions and cancer prevention$76,000
R03 · FY2004 · CA
Characterization of a Novel Growth Regulator$252,700
R01 · FY2003 · CA
COX-2 and p53 interactions and cancer prevention$76,000
R03 · FY2003 · CA
Characterization of a Novel Growth Regulator$252,700
R01 · FY2002 · CA
Death receptors in prostate cancer biology and apoptosis$152,000
R21 · FY2002 · CA
Death receptors in prostate cancer biology and apoptosis$152,000
R21 · FY2001 · CA